Online ISSN: 2331-4737
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

Exploring Oncogenic Driver Molecular Alterations in Hispanic/Latin American Cancer Patients

News

May 3, 2024
PRESS RELEASE: A new editorial paper was published in Oncoscience on April 22, 2024, entitled, “Exploring oncogenic driver molecular alterations in Hispanic/Latin American cancer patients: A call for enhanced molecular understanding.” continue reading »

A Very Long, Winding Road: Developing Novel Therapeutics for Metastatic Tumors

News

February 23, 2024
PRESS RELEASE: On February 9, 2024, a new editorial was published in Oncoscience, entitled, “A very long and winding road: developing novel therapeutics for metastatic tumors.” continue reading »

IPIAD: An Augmentation to Standard Treatment of PDAC Using Five Repurposed Drugs

News

February 9, 2024
PRESS RELEASE: On February 7, 2024, a new research perspective was published in Oncoscience, entitled, “IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone.” continue reading »

Dr. Blagosklonny’s Battle With Cancer (Part 1)

News

January 22, 2024
PRESS RELEASE: On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., published a new brief report in Oncoscience (Volume 11), entitled, “My battle with cancer. Part 1.” continue reading »